Since AD is associated with astrocyte activation, we suggest that higher AQP5 expression found in APP/PS1 mice compared to wt mice could be associated with AD astrogliosis, indicating a potential role of AQP5 in astrocyte response to AD pathology. Here, AQP5 is linked to Alzheimer disease.